Company / Operating Income
Beam Therapeutics Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$383.7M
FY2025
5-year range
-$415.6M / -$176.5M
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
#176 of 204
Health Care
What the data says
Beam Therapeutics Inc.'s operating income of -$384M is lower than 86% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 7 years, ranging from -$416M in FY2024 to -$75M in FY2020.
Based on SEC 10-K filings.
-$384M in FY2025.
Declined from -$176M to -$384M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 204This company -$383.7M Sector average $107.7M
▼
-456.2% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 7.7% year-over-year.
- Ranks #176 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$383.7M | +7.7% |
| FY2024 | -$415.6M | -135.5% |
| FY2023 | -$176.5M | +47.9% |
| FY2022 | -$338.5M | +13.8% |
| FY2021 | -$392.5M | -422.2% |
| FY2020 | -$75.2M | +0.0% |
| FY2019 | -$75.2M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026